Clinical trials: Financial Burden
Carcinoma, Renal Cell
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
Information on the prevalence of advanced/metastatic renal cell carcinoma and its symptom burden is limited in commercially insured adult patients.
- Trial name
- NCT01381601
- Testing
- Targeted agents indicated in management of advanced/metastatic RCC (sunitinib, sorafenib, bevacizumab, and pazopanib)
- Volunteers
- 1 people
- Sponsor
- GlaxoSmithKline
Rheumatoid Arthritis
Health Outcomes in Rheumatoid Arthritis in Greece
Rheumatoid Arthritis (RA) is a chronic debilitating disease, causing severe pain and progressive joint destruction and leading to partial loss of mobility.
- Trial name
- HORA (NCT01001182)
- Testing
- non interventional
- Where
- 7 sites in Greece
- Volunteers
- 210 people
- Sponsor
- Pfizer